EU pharma package is delayed
This article was originally published in Scrip
The European Commissionhas delayed its long-awaited package of legislative proposals for the pharmaceutical sector (Scrip Online, October 2nd, 2008). The draft document was scheduled for release on October 21st, but it requires "technical changes" and the commission has not set a date for releasing a new version.
You may also be interested in...
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.